AGAMREE

Vamorolone · Catalyst Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AGAMREE, covering 2023-10-26 to 2026-04-08. Get the full timeline:

Most recent: EMA Authorised: Agamree (vamorolone) — Santhera Pharmaceuticals (Deutschland) GmbH